SELLAS Life Sciences Group, Inc. (SLS)
↓ Download CSV- Sector Manufacturing
- Incorporated DE
- Fiscal year ends Dec 31
Key ratios (FY2025)
-37.9%
Return on equity
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | $0 | $1.00M | $7.60M | $1.90M | $0 | — | — | — |
| Cost of Revenue | $0 | $0 | $0 | $100.0K | $200.0K | $0 | — | — | — | — |
| Operating Income | -$28.27M | -$31.51M | -$37.87M | -$41.95M | -$25.29M | -$16.98M | -$20.04M | — | -$23.04M | -$15.99M |
| Net Income | -$26.86M | -$30.88M | -$37.34M | -$41.30M | -$20.70M | -$16.76M | -$19.29M | -$27.67M | -$23.75M | -$17.68M |
| EPS (Diluted) | $-0.25 | $-0.50 | $-1.34 | $-2.13 | $-1.34 | $-2.11 | — | — | — | — |
| Total Assets | $78.34M | $19.43M | $6.22M | $20.94M | $26.27M | $46.05M | $16.61M | $16.91M | $33.53M | $6.42M |
| Total Liabilities | $7.47M | $9.97M | $14.20M | $16.09M | $5.93M | $18.09M | $10.52M | $11.67M | $31.46M | $11.42M |
| Shareholders' Equity | $70.87M | $9.46M | -$7.98M | $4.85M | $20.35M | $27.96M | $6.09M | $5.25M | $2.07M | -$5.00M |
| Cash & Equivalents | $71.79M | $13.89M | $2.53M | $17.12M | $21.36M | $35.30M | $7.28M | $5.34M | $2.32M | $5.96M |
| Operating Cash Flow | -$28.39M | -$35.40M | -$31.41M | -$23.81M | -$26.02M | -$10.42M | -$17.64M | -$30.42M | -$10.99M | -$11.85M |
| Capital Expenditures | — | — | — | — | — | — | — | — | — | $6.0K |
| Shares Outstanding | 153.10M | 73.98M | 32.13M | 21.01M | 15.90M | 14.25M | 5.08M | 440.5K | 5.77M | 1.27M |